Representative before the EPO
Partner/Owner

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 59 EP applications Cameron Marshall has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11755497

SMALL LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/00, A61K 39/00, A61K 9/127, A61K 48/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Andrew John Sanderson, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP13166487

Targeted genomic modification with partially single-stranded donor molecules

IPC classification:
C07H 21/00, C12N 15/62, C07K 19/00, C12N 15/90, C12N 9/22
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12713838

ENHANCED CELLULOSE DEGRADATION

IPC classification:
C13K 1/02, C12N 9/42, C12N 9/24, C12N 9/00, C11D 3/386
Applicant:
University of California
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196378

Markers of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and methods of use thereof

IPC classification:
G01N 33/92
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12782478

GENETICALLY ENGINEERED MICROORGANISMS THAT METABOLIZE XYLOSE

IPC classification:
C12P 7/00, C12N 1/13
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12727500

MICROBIAL METABOLISM OF CHLORINE OXYANIONS AS A CONTROL OF BIOGENIC HYDROGEN SULFIDE PRODUCTION

IPC classification:
C12N 15/63, C12N 1/00, C07K 14/195
Applicant:
University of California
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12733249

UTILIZING A MULTIPHASE REACTOR FOR THE CONVERSION OF BIOMASS TO PRODUCE SUBSTITUTED FURANS

IPC classification:
C12P 17/04, C07D 307/50, C07D 307/46
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12702153

RSV IMMUNIZATION REGIMEN

IPC classification:
A61P 31/14, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12743037

COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

IPC classification:
G01N 33/53, C12Q 1/68, C07K 14/005
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12718460

ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13163405

Small animal model for HCV replication

IPC classification:
A61K 38/00, A01K 67/027, A01K 67/00
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722057

PRE-FUSION RSV F ANTIGENS

IPC classification:
C07K 14/135
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13185690

Vaccines including antigen from four strains of influenza virus

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12778013

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

IPC classification:
A61K 39/25, A61K 39/245, C12N 15/86
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12797981

ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP14150138

4-Methylpyrazole formulations

IPC classification:
A61K 31/415, A61K 9/48, A61P 25/32
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
The patent has been granted
EP12791061

IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

IPC classification:
A61K 39/39, A61K 39/385, A61K 39/21
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12769787

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 39/39, A61K 9/127, A61K 9/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12735420

IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/295, A61K 39/12, A61K 39/00, C07K 14/045, C07K 14/015
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
The patent has been granted
EP12738679

LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

IPC classification:
A61K 39/39, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12781365

FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

IPC classification:
A61K 39/05
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12738311

OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

IPC classification:
A61K 39/00, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12743273

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 47/24, A61K 47/06, A61K 39/00, A61K 9/107
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12818607

ASSAY FOR INFLUENZA VIRUS HEMAGGLUTININS

IPC classification:
G01N 33/569
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12815957

ALGAL THERMOPLASTICS, THERMOSETS, PAPER, ADSORBANTS AND ABSORBANTS

IPC classification:
C12N 1/12, C08L 101/16, B01J 20/22
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14160481

Alphavirus vectors for RSV and PIV vaccines

IPC classification:
A61K 39/295, A61K 39/215, A61K 39/155, A61K 39/145, A61K 39/12, A61K 39/02, A61K 39/00, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Nicholas James Finnie, Novartis Pharma AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14187138

Detoxified Escherichia coli immunogens

IPC classification:
A61K 39/108
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Andrew John Sanderson, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12800536

METHODS OF PRODUCING CARBAMOYL PHOSPHATE AND UREA

IPC classification:
C12P 17/12, C12P 13/10, C12P 13/00, C12N 9/12, C07H 21/04, C02F 101/16, C02F 3/34
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12817789

CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

IPC classification:
A01N 43/54, C07D 471/04, C07D 239/42
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14189933

Alphavirus vectors for influenza virus vaccines

IPC classification:
A61K 39/295, A61K 39/215, A61K 39/155, A61K 39/145, A61K 39/12, A61K 39/02, A61K 39/00, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Nicholas James Finnie, Novartis Pharma AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12874745

METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS

IPC classification:
A61K 31/216, A61K 31/185
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
HGF Limited
Status:
PATENT GRANTED
EP13726225

IMPROVED SAFETY TESTING

IPC classification:
A61K 39/12, C12Q 1/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION WITHDRAWN
EP13747515

VACCINES FOR SEROGROUP X MENINGOCOCCUS

IPC classification:
A61K 39/095
Applicant:
Institut Pasteur
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13732536

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/21
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13745892

AUTO-ANTIGEN BIOMARKERS FOR LUPUS

IPC classification:
G01N 33/564
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728300

POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF

IPC classification:
C07C 69/732, C07C 69/675, C07C 69/533, C07C 67/31, C07C 67/03, C07C 57/15, C07C 51/16, C07C 29/09, C07C 11/167, C07C 1/24
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP14192835

A variant form of urate oxidase and use thereof

IPC classification:
A61K 47/48, A61K 38/44, C12N 9/72, C12N 9/06
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13857455

METHODS OF ADMINISTERING AND EVALUATING NITROGEN SCAVENGING DRUGS FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY

IPC classification:
A61K 49/00, A61K 31/19
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
HGF Limited
Status:
EXAMINATION IN PROGRESS
EP11804867

FLOW CYTOMETRY ANALYSIS OF MATERIALS ADSORBED TO METAL SALTS

IPC classification:
G01N 33/537, G01N 33/84, G01N 33/68, G01N 33/569
Applicant:
Novartis AG
Agent:
Antoine Courgeon, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP15156612

Variant forms of urate oxidase and use thereof

IPC classification:
A61K 47/48, C12N 9/06
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14714825

TOBACCO INBRED AND HYBRID PLANTS AND USES THEREOF

IPC classification:
C12N 15/82, C12N 9/10, A01H 5/12
Applicant:
North Carolina State University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15182862

NEISSERIAL ANTIGENIC PEPTIDES

IPC classification:
G01N 33/569, G01N 33/53, A61K 48/00, A61K 39/40, A61K 39/095, C07K 16/12, C07K 14/22, C12N 15/31
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14769502

THIOESTERASES AND CELLS FOR PRODUCTION OF TAILORED OILS

IPC classification:
C12N 9/00, C12N 5/02, C12N 5/00, C12P 7/64
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14785518

PARALLELIZED SAMPLE HANDLING

IPC classification:
B81B 7/04
Applicant:
California Institute of Technology
Applicant:
University of Chicago
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14814315

METHODS FOR ANALYZING CYSTEAMINE COMPOSITIONS

IPC classification:
B01D 15/32, G01N 30/89, G01N 30/34, G01N 30/16, G01N 30/04, G01N 21/33
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14813132

DELAYED RELEASE CYSTEAMINE BEAD FORMULATION

IPC classification:
A01N 33/08, A61K 9/32
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14744940

A CARTRIDGE, CARTRIDGE READER AND METHOD FOR PREVENTING REUSE OF THE CARTRIDGE

IPC classification:
B01L 3/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13164769

Improved methods for preparing squalene

IPC classification:
A61P 31/16, A61K 47/06, A61K 39/39, A61K 31/01, A61K 9/107, C07C 7/04, C07C 11/21
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11767067

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

IPC classification:
A61M 37/00, A61K 9/14, A61K 39/145, A61K 39/00, A61B 17/00, A61B 17/20
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP14784356

LABELLING COMPOUNDS AND THEIR USE IN ASSAYS

IPC classification:
C12Q 1/68, C07F 17/02
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP11805925

NOVEL FERROCENE LABELS FOR ELECTROCHEMICAL ASSAY AND THEIR USE IN ANALYTICAL METHODS

IPC classification:
G01N 27/00, C12Q 1/68, C07F 17/02
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12198671

Vaccination with multiple clades of H5 influenza A virus

IPC classification:
A61K 39/145
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11764862

GENERIC ASSAYS FOR DETECTION OF MAMMALIAN REOVIRUS

IPC classification:
C12Q 1/70
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12741997

TAILORED OILS PRODUCED FROM RECOMBINANT OLEAGINOUS MICROORGANISMS

IPC classification:
C12P 7/64, C12N 15/52, C12N 9/16, C12N 9/10, C12N 9/02, C12N 1/13
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15734548

HIGH-PROTEIN FOOD PRODUCTS MADE USING HIGH-PROTEIN MICROALGAE

IPC classification:
A23L 23/00, A23L 2/02, A23L 2/68, A23L 2/66, A23L 33/10
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15857339

METHODS OF TREATING HUNTINGTON'S DISEASE USING CYSTEAMINE COMPOSITIONS

IPC classification:
A61K 31/13, A61K 31/145, A61P 25/28
Agent:
Boult Wade Tennant Ltd
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16709814

LIPID EXTRACTION PROCESSES

IPC classification:
C11C 1/08, C11C 1/02, C11C 1/00, C11B 3/00, C11B 1/10, A61K 35/612, A23J 7/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16797021

IMPROVED URICASE SEQUENCES AND METHODS OF TREATMENT

IPC classification:
C12N 15/53, C12N 15/09, C12N 9/06, A61P 19/06, A61K 38/44, A61K 38/43
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
AstraZeneca PLC
Status:
Request for examination was made
EP17192612

METHOD FOR FLOW CYTOMETRY LINKED WITH ELEMENTAL ANALYSIS

IPC classification:
H01J 49/04, G01J 3/443, G01N 15/14, H01J 49/26
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published

Please Sign in to use this feature